PHARMACEUTICAL COMPOSITION (VARIANTS) NO CONTAINING PROTEINS AND PEPTIDES FOR NEUTRALIZATION AND/OR REMOVING ENDOTOXINS FROM BODY Russian patent published in 2005 - IPC

Abstract RU 2248796 C2

FIELD: medicine, toxicology, pharmacy.

SUBSTANCE: according with the first variant the composition contains neutral lipid and therapeutically effective amount of cholanic acid or cholanic acid salt and phospholipid. Neutral lipid presents in the amount from 3% to 50% by mass relatively to the total amount of lipid. According with the second variant the composition contains from 3% to 30% by mass of bile acid or bile acid salt, from 3% to 50% by mass of neutral lipid and from 10% to 95% by mass of phospholipid. Composition is designated for treatment in poisoning with endotoxins. Composition no containing peptides and proteins but containing the combination of phospholipid with cholanic acid proves effective relief or prophylaxis of endotoxemia.

EFFECT: enhanced effectiveness and valuable medicinal properties of composition.

23 cl, 10 dwg, 2 tbl, 10 ex

Similar patents RU2248796C2

Title Year Author Number
PHARMACEUTICAL COMPOSITION NO CONTAINING PROTEINS AND PEPTIDES, METHOD OF TREATMENT OF HUMANS AND ANIMALS SUFFERING WITH ENDOTOXEMIA AND METHOD OF PROPHYLAXIS OF DISEASE 1995
  • Levin Dehniel M.
  • Parker Tomas S.
  • Rubin Ehlbert L.
  • Gordon Brjus R.
  • Saal Stjuart D.
RU2174839C2
TREATMENT AND PREVENTION METHOD OF GRAM-POSITIVE BACTERIA INDUCED DISEASES 2006
  • Levin Dehniel
  • Parker Tomas S.
RU2391985C2
METHOD OF TREATING SEPSIS IN PATIENTS HAVING ALBUMIN, CHOLESTEROL AND HDL LEVELS EXCEEDING MINIMUM THRESHOLDS 2013
  • Levine Daniel M.
  • Parker Thomas S.
  • Gordon Bruce R.
  • Saal Stuart D.
RU2571688C1
PHOSPHOLIPID THERAPEUTIC COMPOSITION WITH NANO-SIZED PARTICLES FOR LIPID STORAGE DISEASE AND COMATOSE STATES AND METHOD FOR PREPARING IT 2010
  • Archakov Aleksandr Ivanovich
  • Guseva Marija Kirillovna
  • Medvedeva Natal'Ja Velorikovna
  • Uchajkin Vasilij Fedorovich
  • Ipatova Ol'Ga Mikhajlovna
  • Tikhonova Elena Georgievna
  • Shironin Aleksandr Vladimirovich
  • Storozhakov Gennadij Ivanovich
RU2448715C1
5-(3,4-DICHLOROPHENYL)-N-(2-HYDROXYCYCLOHEXYL)-6-(2,2,2-TRIFLUOROETHOXY)NICOTINAMIDE AND ITS SALT AS AGENTS INCREASING HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION 2010
  • Shtefan Rever
  • Matt'Ju Rajt
RU2541475C2
POWDER-LIKE COMPOSITIONS OF UNILAMELLAR LIPOSOMES 1998
  • Sall' Zhan-P'Er
RU2214231C2
LIPOPROTEIN COMPLEXES AND THEIR PREPARATION AND APPLICATION 2012
  • Dasseux Jean-Louis
  • Oniciu Daniela Carmen
  • Ackermann Rose
RU2627173C2
RECONSTITUTED HDL FORMULATION 2013
  • Vuchitsa Ivonne
  • Uorren Geri Li
RU2669568C2
PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION 2006
  • Dikovskij Aleksandr Vladimirovich
  • Rudoj Boris Anatol'Evich
  • Dorozhko Oleg Valentinovich
RU2318538C1
USING LCAT FOR TREATING ANAEMIA AND RED BLOOD CELL DISORDERS 2010
  • Auerbakh Brjus
  • Kraus Brajan
  • Khomen Rejnold
RU2576838C2

RU 2 248 796 C2

Authors

Levin Dehniel M.

Parker Tomas S.

Rubin Ehlbert L.

Gordon Brjus R.

Saal Stjuart D.

Dates

2005-03-27Published

1995-08-10Filed